PRIMARY PERITONEAL
Clinical trials for PRIMARY PERITONEAL explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat ovarian cancer
Disease control Recruiting nowThis study is testing an experimental drug called TORL-1-23 for women with advanced ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to standard platinum-based chemotherapy. The drug specifically targets cancer cells that have a protein called CLD…
Matched conditions: PRIMARY PERITONEAL
Phase: PHASE2 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug trial aims to control Tough-to-Treat ovarian cancer
Disease control Recruiting nowThis study is testing an experimental drug called mirvetuximab soravtansine for women with advanced ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to platinum-based chemotherapy. The main goals are to find the best dosing schedule and to see how…
Matched conditions: PRIMARY PERITONEAL
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Scientists test common Drug's impact on experimental cancer therapy
Knowledge-focused Recruiting nowThis early-phase study aims to understand how a common antifungal medication (itraconazole) affects the levels of a new, experimental cancer drug (AZD5335) in the body. It involves about 24 participants with recurrent ovarian, fallopian tube, or primary peritoneal cancer. The mai…
Matched conditions: PRIMARY PERITONEAL
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC